On Oct. 1, Texas WIC’s new formula contract went into effect.
Texas WIC’s contract for milk-based formulas has switched from Abbott Laboratories, the makers of Similac, to Mead Johnson, the makers of Enfamil products. The new contract is only for milk-based formulas. All other formula products remain unchanged.
“All WIC participants receiving standard milk-based infant formulas will be transitioned to Enfamil products for benefits beginning October 2022,” according to a statement from Texas WIC.
There is a Mead Johnson product equivalent for every Abbott Laboratories product.
If you haven’t already discussed this change with your local WIC office, contact them at your earliest convenience.
“The WIC program is required to have a contract with one specific formula company to help keep costs down. We renew the contract every 5 years. The award for the contract from October 2022 – September 2027 for milk based formula is Mead Johnson, the makers of Enfamil. The soy-based formula will continue to be with Abbott, the makers of Similac,” according to a statement from Texas WIC.